BCRX – BioCryst Pharmaceuticals, Inc.
Name :
Sector :
Industry:
Mark. Cap: $0.0000
EPSttm :
Fair Value
Margin Of Safety %
Put/Call OI Ratio
0.29
Float Short %
12.42
EPS 1 Diff
-0.01
EPS Year Diff
0.81
Ticker: BCRX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-09-06 | BCRX | 7.99 | 0.29 | 0.68 | 47823 |
| 2024-09-09 | BCRX | 7.665 | 0.30 | 1.61 | 48036 |
| 2024-09-10 | BCRX | 7.72 | 0.30 | 0.07 | 48198 |
| 2024-09-11 | BCRX | 7.72 | 0.30 | 0.67 | 48405 |
| 2024-09-12 | BCRX | 7.75 | 0.30 | 0.25 | 48729 |
| 2024-09-13 | BCRX | 7.91 | 0.30 | 1.24 | 48742 |
| 2024-09-16 | BCRX | 7.91 | 0.30 | 0.08 | 48665 |
| 2024-09-17 | BCRX | 7.93 | 0.30 | 0.26 | 48707 |
| 2024-09-18 | BCRX | 7.97 | 0.30 | 0.25 | 48717 |
| 2024-09-19 | BCRX | 8.16 | 0.30 | 0.25 | 48847 |
| 2024-09-20 | BCRX | 8.11 | 0.30 | 0.20 | 48728 |
| 2024-09-23 | BCRX | 7.8 | 0.28 | 0.03 | 38974 |
| 2024-09-24 | BCRX | 7.63 | 0.28 | 0.07 | 39363 |
| 2024-09-25 | BCRX | 7.55 | 0.28 | 0.39 | 39528 |
| 2024-09-26 | BCRX | 7.58 | 0.28 | 1.00 | 39533 |
| 2024-09-27 | BCRX | 7.62 | 0.28 | 0.22 | 39660 |
| 2024-09-30 | BCRX | 7.6 | 0.28 | 0.20 | 39804 |
| 2024-10-01 | BCRX | 7.38 | 0.28 | 0.07 | 39751 |
| 2024-10-02 | BCRX | 7.38 | 0.28 | 0.16 | 39895 |
| 2024-10-03 | BCRX | 7.41 | 0.28 | 0.01 | 39935 |
| 2024-10-04 | BCRX | 7.57 | 0.29 | 0.61 | 39975 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-09-06 | BCRX | 7.99 | 68.4 | - | -0.37 |
| 2024-09-09 | BCRX | 7.66 | 68.4 | - | -0.37 |
| 2024-09-10 | BCRX | 7.72 | 68.4 | - | -0.37 |
| 2024-09-11 | BCRX | 7.73 | 68.4 | - | -0.37 |
| 2024-09-12 | BCRX | 7.75 | 68.4 | - | -0.37 |
| 2024-09-13 | BCRX | 7.91 | 68.4 | - | -0.37 |
| 2024-09-16 | BCRX | 7.91 | 68.4 | - | -0.37 |
| 2024-09-17 | BCRX | 7.97 | 68.4 | - | -0.37 |
| 2024-09-18 | BCRX | 7.96 | 68.4 | - | -0.37 |
| 2024-09-19 | BCRX | 8.16 | 68.4 | - | -0.37 |
| 2024-09-20 | BCRX | 8.12 | 68.4 | - | -0.37 |
| 2024-09-23 | BCRX | 7.79 | 68.4 | - | -0.37 |
| 2024-09-24 | BCRX | 7.62 | 68.4 | - | -0.37 |
| 2024-09-25 | BCRX | 7.55 | 68.4 | - | -0.37 |
| 2024-09-26 | BCRX | 7.58 | 68.4 | - | -0.37 |
| 2024-09-27 | BCRX | 7.62 | 68.4 | - | -0.37 |
| 2024-09-30 | BCRX | 7.59 | 68.4 | - | -0.37 |
| 2024-10-01 | BCRX | 7.38 | 68.4 | - | -0.37 |
| 2024-10-02 | BCRX | 7.38 | 68.4 | - | -0.37 |
| 2024-10-03 | BCRX | 7.42 | 68.4 | - | -0.37 |
| 2024-10-04 | BCRX | 7.57 | 68.4 | - | -0.37 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-09-06 | BCRX | 1.49 | -1.63 | 12.67 |
| 2024-09-09 | BCRX | 1.49 | -1.63 | 12.67 |
| 2024-09-10 | BCRX | 1.49 | -1.63 | 12.67 |
| 2024-09-11 | BCRX | 1.49 | -1.63 | 12.67 |
| 2024-09-12 | BCRX | 1.49 | -1.63 | 12.29 |
| 2024-09-13 | BCRX | 1.49 | -1.63 | 12.29 |
| 2024-09-16 | BCRX | 1.49 | -1.63 | 12.29 |
| 2024-09-17 | BCRX | 1.49 | -1.63 | 12.29 |
| 2024-09-18 | BCRX | 1.49 | -1.63 | 12.29 |
| 2024-09-19 | BCRX | 1.49 | -1.63 | 12.29 |
| 2024-09-20 | BCRX | 1.49 | -1.63 | 12.29 |
| 2024-09-23 | BCRX | 1.49 | -1.63 | 12.29 |
| 2024-09-24 | BCRX | 1.49 | -1.63 | 12.29 |
| 2024-09-25 | BCRX | 1.49 | -1.63 | 12.42 |
| 2024-09-26 | BCRX | 1.49 | -1.63 | 12.42 |
| 2024-09-27 | BCRX | 1.49 | -1.63 | 12.42 |
| 2024-09-30 | BCRX | 1.51 | -1.63 | 12.42 |
| 2024-10-01 | BCRX | 1.51 | -1.63 | 12.42 |
| 2024-10-02 | BCRX | 1.51 | -1.63 | 12.42 |
| 2024-10-03 | BCRX | 1.51 | -1.63 | 12.42 |
| 2024-10-04 | BCRX | 1.51 | -1.63 | 12.42 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.06
Avg. EPS Est. Current Quarter
-0.06
Avg. EPS Est. Next Quarter
-0.07
Insider Transactions
1.51
Institutional Transactions
-1.63
Beta
1.9
Average Sales Estimate Current Quarter
112
Average Sales Estimate Next Quarter
115
Fair Value (Academic)
Quality Score
38
Growth Score
55
Sentiment Score
52
Actual DrawDown %
62.1
Max Drawdown 5-Year %
-79.1
Target Price
14.45
P/E
Forward P/E
PEG
P/S
4.1
P/B
P/Free Cash Flow
EPS
-0.73
Average EPS Est. Cur. Y
-0.37
EPS Next Y. (Est.)
-0.18
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-38.18
Relative Volume
0.47
Return on Equity vs Sector %
9.1
Return on Equity vs Industry %
-12.1
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
stock quote shares BCRX – BioCryst Pharmaceuticals, Inc. Stock Price stock today
news today BCRX – BioCryst Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch BCRX – BioCryst Pharmaceuticals, Inc. yahoo finance google finance
stock history BCRX – BioCryst Pharmaceuticals, Inc. invest stock market
stock prices BCRX premarket after hours
ticker BCRX fair value insiders trading